AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving ...

(Reuters) -AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on ...

AstraZeneca was among the first multinational pharmaceutical firms to invest deeply in China's healthcare sector. Through ...

AstraZeneca has seen its fair value per share revised upward from $140.96 to $144.38. This change reflects growing analyst ...

If it wasn’t already clear, Virginia is doubling down on life sciences. State officials have teamed up with a trio of top ...

AstraZeneca has breached the UK pharmaceutical industry's code of practice, an industry self-regulatory body ruled on Friday, ...

British pharmaceutical giant AstraZeneca ($AZN) is one step closer to its strategic shift towards the U.S., its largest ...

AstraZeneca said work on its new plant north of Charlottesville will begin immediately and be open within five years.

The decision by the Canadian regulator is supported by the findings from the Phase III DESTINY-Breast06 study.

These pivotal studies investigated AstraZeneca and Daiichi Sankyo’s Enhertu, a human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugate with a topoisomerase II-targeting ...

The chief scientific officer of AstraZeneca says breast-cancer drugs that the company highlighted at an industry conference ...

Virginia will be home to a workforce training center preparing thousands of people each year for a career in the pharmaceutical industry.